Clinical trial to study the efficacy of Transcendental Meditation for lowering blood pressure
Phase 1
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2020/05/025051
- Lead Sponsor
- AIIMS Rishikesh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Participants having elevated or stage I category of blood pressure with 10 year ASCVD risk < 10% (Not requiring pharmacotherapy, according to AHA guidelines 2019)
2. Participants are willing to participate in the study for the next 6 months
Exclusion Criteria
Participants having any of following condition will be excluded:
1. History of Hypertension stage-II & hypertensive crisis
2. Taking Anti-Hypertensive medications
3. Diagnosed cases of Cardiovascular disease, Diabetes mellitus, Chronic kidney disease, Ischemic heart disease
4. Psychiatric disorder (psychoses, substance abuse, dementia)
5. Pregnant women
6. any other life-threatening medical illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in blood pressureTimepoint: Baseline and monthly till first 3 months then at 6th month
- Secondary Outcome Measures
Name Time Method 1. Improvement in selective attention <br/ ><br>2. Improvement in anxiety <br/ ><br>3. Increase in happiness <br/ ><br>4. Reduction in stress <br/ ><br>5. Change in cortisol level <br/ ><br>Timepoint: Baseline and monthly till first 3 months then at 6th month